Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 236 (8%)
Anticipated shortage: 18 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

30 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ZAMINE 28 3.0MG 0.030MG TABLET Resolved 2017-03-11 2020-09-04 561
ZAMINE 28 3MG 0.03MG TABLET Resolved 2021-02-12 2021-03-10 133984
ZAMINE 28 0.03MG 3MG TABLET Resolved 2023-09-07 2023-09-28 203831
ZAMINE 28 0.03MG 3MG TABLET Resolved 2023-11-24 2023-12-22 211487
ZAMINE 28 0.03MG 3MG TABLET Resolved 2024-01-26 2024-03-08 217475
ZAMINE 21 3.0MG 0.030MG TABLET Resolved 2017-03-11 2020-09-04 558
ZAMINE 21 0.03MG 3MG TABLET Resolved 2023-06-16 2023-07-27 195081
ZAMINE 21 0.03MG 3MG TABLET Resolved 2023-11-17 2023-12-22 210668
ZAMINE 21 0.03MG 3MG TABLET Resolved 2024-02-02 2024-03-29 218391
APO-TRIMEBUTINE 100MG TABLET Resolved 2021-11-24 2021-12-24 149793
APO-TRIMEBUTINE 100MG TABLET Resolved 2023-02-03 2023-04-17 183589
APO-TRIMEBUTINE 100MG TABLET Resolved 2023-07-14 2023-08-14 198716
TRI-CIRA LO 21 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2018-01-18 2018-02-23 36429
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2018-12-27 2019-01-23 70526
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-03-05 2019-05-21 77902
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-03-13 2019-05-21 78558
TRI-CIRA LO 21 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-04-10 2019-08-26 80931
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-08-07 2019-08-26 91109
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-11-13 2019-11-18 98575
TRI-CIRA LO 21 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG TABLET Resolved 2022-02-22 2022-03-07 155371

Showing 1 to 20 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-HYDROMORPHONE CR 4.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110974
APO-HYDROMORPHONE CR 9MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110977
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-FLUVOXAMINE 100MG TABLET Discontinued 2017-03-30 2018-02-05 4713
APO-FLUVOXAMINE 50MG TABLET Discontinued 2017-03-30 2018-02-05 4716
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-FENTANYL MATRIX 100MCG PATCH Discontinued 2018-02-23 2018-12-28 40741
APO-FENTANYL MATRIX 25MCG PATCH Discontinued 2018-09-07 2018-09-15 60489
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497

Showing 181 to 200 of 356